June 19, 2018 – Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the fully automated clip selection and calculation of left ventricular ejection fraction (EF). EF is the single most widely used metric of cardiac function and used as the basis for many clinical decisions. The EchoMD AutoEF algorithms eliminate the need to manually select views, choose the best clips and manipulate them for quantification, an often time-consuming and highly variable process.
“Left ventricular ejection fraction has been a mainstay of echocardiography for the last 50 years. Bay Labs’ use of artificial intelligence for image selection and automated EF measurement will allow clinicians across a wide range of experience to obtain accurate evaluation of ventricular function and aid in interpretation of the echocardiograms with greater efficiency,” said Neil J. Weissman, M.D., FACC, FASE, chief scientific officer for MedStar Health, president of MedStar Health Research Institute and a professor of medicine at Georgetown University School of Medicine. “This will ultimately result in more effective care for our patients.”
Unlike current technologies, EchoMD AutoEF automatically reviews all the relevant digital video clips of cardiac cycles from a patient’s echocardiography study, rates them according to image quality and selects the best ones to calculate the EF. The EchoMD AutoEF software algorithm “learned” clip selection and EF calculation after being trained on a carefully curated dataset of over 4 million images representing 9,000 patients. Through partnerships with leading cardiology clinical institutions and its expertise in the processing of large diagnostic imaging datasets, Bay Labs has created a massive archive of carefully curated studies optimized for deep learning algorithm development.
EchoMD AutoEF software can be integrated into any DICOM picture archiving and communication system (PACS) medical imaging environment and provides cardiologists with results as a seamless part of routine diagnostic workflow. Bay Labs will make EchoMD AutoEF available to support fast, efficient and accurate AI-assisted echocardiogram analysis to ensure the highest quality care for patients.
For more information: www.baylabs.io
March 06, 2026 
